Simplex Trading
AVBP icon

Simplex Trading’s ArriVent BioPharma AVBP Stock Holding History

Simplex Trading’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Buy
45,000
+15,500
+53% +$457K ﹤0.01% 2274
2026
Q1 		$681K Buy
+29,500
New +$666K ﹤0.01% 2921

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Simplex Trading's AVBP Position: Q2 2026 in Review

Simplex Trading opened a new position in ArriVent BioPharma (AVBP) in Q2 2026: 6,428 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #4570 among its holdings. This is a return to the name: Simplex Trading previously reported a position in AVBP as recently as Q4 2025.

Simplex Trading first reported a position in AVBP in Q2 2025 and has held it in 4 quarters since. The position peaked at $917K in Q4 2025. 158 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Simplex Trading held 6,428 shares of ArriVent BioPharma worth $223K as of Q2 2026.
  • ArriVent BioPharma was a new Simplex Trading position in Q2 2026.
  • ArriVent BioPharma made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4570 holding.
  • Simplex Trading first reported a position in ArriVent BioPharma in Q2 2025 and has held it in 4 quarters since.
  • Simplex Trading's ArriVent BioPharma position peaked at $917K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.